News briefing: British psychedelic investment firm launches; Irish cell therapy company gains exclusive license options
The first investment fund in Britain solely focused on psychedelic health care has launched, and will draw uncapped venture capital …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
